NCT07151768View on ClinicalTrials.gov

Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

September 1, 2028

Conditions

Chronic Lung DiseasePulmonary Hypertension

Interventions

DIAGNOSTIC_TEST

Observational Study

"* assignment of PVD-B65 score derived from standard of care testing~* no therapeutic intervention or other treatment"

Trial Locations (1)

19140

RECRUITING

Temple University Hospital, Philadelphia

All Listed Sponsors

lead

Temple University

OTHER

NCT07151768 - Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension | Biotech Hunter | Biotech Hunter